BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 12421676)

  • 41. Soluble IL-6R alpha upregulated IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells.
    Barillé S; Collette M; Thabard W; Bleunven C; Bataille R; Amiot M
    Cytokine; 2000 Sep; 12(9):1426-9. PubMed ID: 10976008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S; Scheller J; Elson G; Jones SA
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T; Wang J; Minamiguchi H; Fujiki H; Harada S; Okuda K; Kaneko H; Yokota S; Yasukawa K; Abe T; Sonoda Y
    Stem Cells; 2000; 18(6):444-52. PubMed ID: 11072033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. How does interleukin-6 affect the membrane expressions of interleukin-6 receptor and gp130 and the proliferation of the human myeloma cell line OPM-2?
    Kovacs E
    Biomed Pharmacother; 2003 Dec; 57(10):489-94. PubMed ID: 14637393
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling.
    Li H; Wang H; Nicholas J
    J Virol; 2001 Apr; 75(7):3325-34. PubMed ID: 11238858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The N-terminus of gp130 is critical for the formation of the high-affinity interleukin-6 receptor complex.
    Moritz RL; Ward LD; Tu GF; Fabri LJ; Ji H; Yasukawa K; Simpson RJ
    Growth Factors; 1999; 16(4):265-78. PubMed ID: 10427501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IL-6 and Crohn's disease.
    Ito H
    Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):125-30. PubMed ID: 14561164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A complex of the soluble interleukin-6 receptor and interleukin-6 is internalized via the signal transducer gp130.
    Graeve L; Korolenko TA; Hemmann U; Weiergräber O; Dittrich E; Heinrich PC
    FEBS Lett; 1996 Dec; 399(1-2):131-4. PubMed ID: 8980136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. No inhibition of IL-27 signaling by soluble gp130.
    Scheller J; Schuster B; Hölscher C; Yoshimoto T; Rose-John S
    Biochem Biophys Res Commun; 2005 Jan; 326(4):724-8. PubMed ID: 15607729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.
    Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M
    Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission.
    Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ
    Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-6 signal transduction and its physiological roles: the signal orchestration model.
    Kamimura D; Ishihara K; Hirano T
    Rev Physiol Biochem Pharmacol; 2003; 149():1-38. PubMed ID: 12687404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes.
    Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C
    Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance].
    Li Y; Wang Y; Qi L
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jan; 36(1):18-9. PubMed ID: 11778537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.
    Narazaki M; Yasukawa K; Saito T; Ohsugi Y; Fukui H; Koishihara Y; Yancopoulos GD; Taga T; Kishimoto T
    Blood; 1993 Aug; 82(4):1120-6. PubMed ID: 8353278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells.
    Tajima S; Tsuji K; Ebihara Y; Sui X; Tanaka R; Muraoka K; Yoshida M; Yamada K; Yasukawa K; Taga T; Kishimoto T; Nakahata T
    J Exp Med; 1996 Oct; 184(4):1357-64. PubMed ID: 8879208
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.
    Chalaris A; Schmidt-Arras D; Yamamoto K; Rose-John S
    Dig Dis; 2012; 30(5):492-9. PubMed ID: 23108305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-6 receptor independent stimulation of human gp130 by viral IL-6.
    Müllberg J; Geib T; Jostock T; Hoischen SH; Vollmer P; Voltz N; Heinz D; Galle PR; Klouche M; Rose-John S
    J Immunol; 2000 May; 164(9):4672-7. PubMed ID: 10779772
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Soluble IL-6 receptor leads to a paracrine modulation of the IL-6-induced hepatic acute phase response in double transgenic mice.
    Peters M; Odenthal M; Schirmacher P; Blessing M; Fattori E; Ciliberto G; Meyer zum Buschenfelde KH; Rose-John S
    J Immunol; 1997 Aug; 159(3):1474-81. PubMed ID: 9233646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.